"Phospholipases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of enzymes that catalyze the hydrolysis of phosphoglycerides or glycerophosphatidates. EC 3.1.-.
Descriptor ID |
D010740
|
MeSH Number(s) |
D08.811.277.352.100.680 D08.811.277.352.640.700
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Phospholipases".
Below are MeSH descriptors whose meaning is more specific than "Phospholipases".
This graph shows the total number of publications written about "Phospholipases" by people in this website by year, and whether "Phospholipases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phospholipases" by people in Profiles.
-
Sandra F, Degli Esposti M, Ndebele K, Gona P, Knight D, Rosenquist M, Khosravi-Far R. Tumor necrosis factor-related apoptosis-inducing ligand alters mitochondrial membrane lipids. Cancer Res. 2005 Sep 15; 65(18):8286-97.
-
Liu L, Roberts ML, Rittenhouse AR. Phospholipid metabolism is required for M1 muscarinic inhibition of N-type calcium current in sympathetic neurons. Eur Biophys J. 2004 May; 33(3):255-64.
-
Pilitsis JG, Diaz FG, O'Regan MH, Phillis JW. Differential effects of phospholipase inhibitors on free fatty acid efflux in rat cerebral cortex during ischemia-reperfusion injury. Brain Res. 2002 Sep 27; 951(1):96-106.
-
Pilitsis JG, Diaz FG, O'Regan MH, Phillis JW. Inhibition of Na(+)/H(+) exchange by SM-20220 attenuates free fatty acid efflux in rat cerebral cortex during ischemia-reperfusion injury. Brain Res. 2001 Sep 21; 913(2):156-8.
-
Falo LD, Haber SI, Herrmann S, Benacerraf B, Rock KL. Characterization of antigen association with accessory cells: specific removal of processed antigens from the cell surface by phospholipases. Proc Natl Acad Sci U S A. 1987 Jan; 84(2):522-6.
-
Falo LD, Benacerraf B, Rock KL. Phospholipase treatment of accessory cells that have been exposed to antigen selectively inhibits antigen-specific Ia-restricted, but not allospecific, stimulation of T lymphocytes. Proc Natl Acad Sci U S A. 1986 Sep; 83(18):6994-7.
-
Bomalaski JS, Clark MA, Zurier RB. Enhanced phospholipase activity in peripheral blood monocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1986 Mar; 29(3):312-8.
-
Bomalaski JS, Clark MA, Douglas SD, Zurier RB. Enhanced phospholipase A2 and C activities of peripheral blood polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Leukoc Biol. 1985 Nov; 38(5):649-54.
-
Siess W, Boehlig B, Weber PC, Lapetina EG. Prostaglandin endoperoxide analogues stimulate phospholipase C and protein phosphorylation during platelet shape change. Blood. 1985 May; 65(5):1141-8.
-
van Kuijk FJ, Handelman GJ, Dratz EA. Consecutive action of phospholipase A2 and glutathione peroxidase is required for reduction of phospholipid hydroperoxides and provides a convenient method to determine peroxide values in membranes. J Free Radic Biol Med. 1985; 1(5-6):421-7.